A STUDY ON ADHERENCE PATTERNS , TOXICITIES AND QUALITY OF LIFE OF PATIENTS WITH PROGRESSIVE ADULT MALIGNANCIES ON METRONOMIC CHEMOTHERAPY
暂无分享,去创建一个
P. Thennarasu | A. Ramesh | Vanitha Rani | S. Abhinaya | Likitha Chowdary | M. Malathi | Sindhu Chowdary
[1] O. Tsitsilonis,et al. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients , 2014, Experimental Hematology & Oncology.
[2] K. Mross,et al. Metronomic anti-cancer therapy - an ongoing treatment option for advanced cancer patients , 2012 .
[3] D. Generali,et al. Use of metronomic chemotherapy in oncology: results from a national Italian survey. , 2011, Tumori.
[4] N. André,et al. Children Treated With Metronomic Chemotherapy in a Low-income Country: METRO-MALI-01 , 2011, Journal of pediatric hematology/oncology.
[5] Nicolas André,et al. Metronomic chemotherapy: new rationale for new directions , 2010, Nature Reviews Clinical Oncology.
[6] U. Dafni,et al. Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer , 2009, Clinical Cancer Research.
[7] N. André,et al. Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: a preliminary monocentric study. , 2008, Clinical therapeutics.
[8] N. André,et al. Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment. , 2007, Current cancer drug targets.
[9] C. Tiu,et al. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer , 2007, Cancer Chemotherapy and Pharmacology.
[10] P. Cano,et al. Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors , 2006, Clinical Cancer Research.
[11] Robert S. Kerbel,et al. The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.
[12] C. Unger,et al. Palliative Chemotherapy in Pretreated Patients with Advanced Cancer: Oral Trofosfamide Is Effective in Ovarian Carcinoma , 2001, Cancer investigation.
[13] J. Folkman,et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. , 2000, Cancer research.
[14] A. Nacci,et al. Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer. , 2012, European journal of cancer.